首页 >
法规速递
-
Document: Annex 4 - Initial Qualification Procedure List of Issues and Replies - Virtual Control Groups-2026/3/31
2026-04-01查看详情 > -
Document: Annex 3 - CHMP Scientific Advice - Summary Qualification Document-2026/3/31
2026-04-01查看详情 > -
Page: Scientific publications-2026/3/31
2026-04-01查看详情 > -
Document: Annex 1 - Standard Operating Procedure for the Implementation of Virtual Control Groups in Preclinical Studies-2026/3/31
2026-04-01查看详情 > -
Page: European medicines agencies network strategy (EMANS)-2026/3/31
2026-04-01查看详情 > -
Document: European medicines agencies network strategy (EMANS) to 2025: Final report-2026/3/31
2026-04-01查看详情 > -
Page: Pharmaceutical industry-2026/3/31
2026-04-01查看详情 > -
Page: Classification of changes: questions and answers-2026/3/27
2026-03-30查看详情 > -
Page: Changing the labelling and package leaflet (Article 61(3) notifications)-2026/3/27
2026-03-30查看详情 > -
Document: Timetable: Initial (full) marketing authorisation application assessment-2026/3/27
2026-03-30查看详情 >
